ANIK Anika Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ 10-K/10-Q Jul 29, 2026
$21.42
· of 52w range
· above low
· to high
$9.0152w low
$22.8852w high
Market Cap (MRQ)
$287M
P/E (TTM)
-79.3
EPS (TTM)
$-0.27
Revenue (TTM)
$121M
your badges
52W Range
$9–$23
Analyst Rating
BUY
Price Target
$23
P/E
-79.3
ROE
-2.7%
Net Profit Margin
-3.1%
Your badge strip is empty — pin a metric anywhere on this page.
ANIK Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$21.42
Market Cap (MRQ)
$287M
P/E (TTM)
-79.3
EPS (TTM)
$-0.27
Revenue (TTM)
$121M
ROE (TTM)
-2.7%
52W Range
$9–$23
ANIK Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$113M2016-12-31 → 2025-12-31
EPS$-0.762016-12-31 → 2025-12-31
Free Cash Flow$4M2016-12-31 → 2025-12-31
Net margin-3.1%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ANIK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -79.35Y avg ≈15.6 | ≈15.6 | · | · | |
| P/S (TTM) | 2.45Y avg ≈2.6 | ≈2.6 | 44.7 | Undervalued | |
| P/B (MRQ) | 2.15Y avg ≈1.4 | ≈1.4 | 2.5 | Undervalued | |
| Price / FCF (TTM) | 510.15Y avg ≈-13.2 | ≈-13.2 | · | · | |
| Price / Cash Flow (TTM) | 48.05Y avg ≈53.9 | ≈53.9 | · | · | |
| Price / Tangible Book (MRQ) | 2.15Y avg ≈1.8 | ≈1.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ANIK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 62.2%5Y avg ≈59.0% | ≈59.0% | · | · | |
| Operating Margin (TTM) | -4.2%5Y avg ≈-6.2% | ≈-6.2% | -164.5% | Top tier | |
| EBITDA Margin | -9.8%5Y avg ≈-6.2% | ≈-6.2% | -164.5% | Top tier | |
| Pretax Margin (TTM) | -2.4%5Y avg ≈-5.2% | ≈-5.2% | -177.4% | Top tier | |
| Net Profit Margin (TTM) | -3.1%5Y avg ≈-15.8% | ≈-15.8% | -524.3% | Top tier | |
| ROA (TTM) | -2.0%5Y avg ≈-8.1% | ≈-8.1% | -3.5% | Below avg | |
| ROE (TTM) | -2.7%5Y avg ≈-11.3% | ≈-11.3% | 3.5% | Weak | |
| ROIC | -8.3%5Y avg ≈-5.7% | ≈-5.7% | -12.8% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ANIK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.55Y avg ≈5.3 | ≈5.3 | 6.2 | Low liquidity | |
| Quick Ratio | 4.85Y avg ≈4.7 | ≈4.7 | 5.0 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | ANIK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -5.9%5Y avg ≈-2.0% | ≈-2.0% | · | · | |
| Revenue CAGR 3Y | -0.30%5Y avg ≈-3.2% | ≈-3.2% | · | · | |
| Revenue CAGR 5Y | -2.9% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ANIK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.65Y avg ≈0.5 | ≈0.5 | 0.3 | Top tier | |
| Inventory Turnover | 2.35Y avg ≈1.8 | ≈1.8 | · | · | |
| Receivables Turnover | 4.85Y avg ≈4.9 | ≈4.9 | · | · | |
| Revenue / Employee | ≈$480.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
148.4%
Next Report
Nov 03, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 28, 2026 | $0.42 | $-0.08 | 614.7% |
| March 31, 2026 | May 7, 2026 | $0.27 | $-0.16 | 265.4% |
| Dec. 31, 2025 | $0.02 | $-0.22 | 109.1% | |
| Sept. 30, 2025 | $-0.16 | $-0.28 | 41.9% | |
| June 30, 2025 | $-0.28 | $-0.26 | -8.4% | |
| March 31, 2025 | $-0.34 | $-0.15 | -132.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113M | $120M | $121M | $114M | $148M | $130M | $115M | $106M | $113M | $103M | $93M | $106M | |
| Cost of Revenue | $49M | $44M | $38M | $41M | $65M | $61M | $29M | $31M | $27M | $24M | $21M | $21M | |
| Gross Profit | $64M | $76M | $83M | $73M | $83M | $69M | $86M | $74M | · | · | · | · | |
| R&D Expense | $26M | $26M | $22M | $18M | $27M | $23M | $17M | $18M | $19M | $11M | $9M | $8M | |
| SG&A Expense | $49M | $56M | $60M | $51M | $74M | $60M | $35M | $34M | $22M | $18M | $15M | $15M | |
| Operating Expenses | $75M | $81M | $82M | $70M | $80M | $97M | $52M | $53M | $68M | $53M | $45M | $44M | |
| Operating Income | $-11M | $-5M | $844.0K | $4M | $3M | $-28M | $34M | $22M | $46M | $51M | $48M | $61M | |
| Pretax Income | $-9M | $-3M | $3M | $4M | $2M | $-29M | $36M | $23M | $46M | $51M | $48M | $62M | |
| Income Tax | $672.0K | $6M | $7M | $2M | $-2M | $-5M | $9M | $4M | $14M | $18M | $17M | $23M | |
| Net Income | $-11M | $-56M | $-83M | $-15M | $4M | $-24M | $27M | $19M | $32M | $33M | $31M | $38M | |
| EPS (Basic) | $-0.76 | $-3.83 | $-5.64 | $-1.02 | $0.29 | $-1.69 | $1.93 | $1.30 | $2.18 | $2.22 | $2.06 | $2.61 | |
| EPS (Diluted) | $-0.76 | $-3.83 | $-5.64 | $-1.02 | $0.28 | $-1.69 | $1.89 | $1.27 | $2.11 | $2.15 | $2.01 | $2.51 | |
| Shares (Basic) | 14,339,000 | 14,721,000 | 14,656,000 | 14,561,000 | 14,401,000 | 14,222,000 | 14,121,000 | 14,442,000 | 14,575,000 | 14,682,000 | 14,934,000 | 14,678,000 | |
| Shares (Diluted) | 14,339,000 | 14,721,000 | 14,656,000 | 14,787,000 | 14,634,000 | 14,222,000 | 14,374,000 | 14,689,000 | 15,068,000 | 15,116,000 | 15,321,000 | 15,269,000 | |
| EBITDA | $-11M | $-5M | · | $-19M | $3M | $-28M | $34M | $22M | $46M | $51M | $48M | $61M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $56M | $69M | $86M | $94M | $96M | $157M | $89M | $133M | $104M | $111M | $100M | |
| Short-term Investments | $24M | $24M | $26M | $35M | $30M | $3M | $27M | $70M | $24M | $20M | $28M | $7M | |
| Receivables | $24M | $24M | $26M | $35M | $30M | $24M | $23M | $21M | $24M | $28M | $22M | $17M | |
| Inventory | $19M | $24M | $24M | $40M | $36M | $46M | $22M | $21M | $22M | $16M | $15M | $12M | |
| Prepaid Expense | $3M | $5M | $7M | $9M | $8M | $9M | $4M | $2M | $3M | $2M | $1M | $1M | |
| Current Assets | $103M | $114M | $163M | $170M | $169M | $177M | $234M | $203M | $206M | $170M | $176M | $138M | |
| PP&E (Net) | $40M | $39M | $37M | $48M | $48M | $51M | $51M | $54M | $56M | $52M | $40M | $32M | |
| PP&E (Gross) | $92M | $85M | $81M | $94M | $87M | $85M | $79M | $78M | $76M | $79M | $65M | $54M | |
| Accum. Depreciation | $51M | $46M | $44M | $46M | $40M | $35M | $29M | $24M | $20M | $27M | $25M | $22M | |
| Goodwill | $8M | $7M | $8M | $7M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | |
| Intangibles | $2M | $2M | $3M | $75M | $82M | $91M | $8M | $9M | $11M | $10M | $12M | $15M | |
| Other Non-current Assets | $4M | $6M | $6M | $17M | $20M | $15M | $7M | $5M | $1M | $69.0K | · | · | |
| Total Assets | $190M | $203M | $271M | $349M | $348M | $366M | $331M | $279M | $283M | $240M | $236M | $193M | |
| Accounts Payable | $6M | $6M | $6M | $9M | $8M | $9M | $4M | $3M | $7M | $2M | $8M | $1M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | $6M | $6M | $6M | $5M | |
| Current Liabilities | $22M | $23M | $31M | $28M | $30M | $37M | $16M | $11M | $13M | $9M | $17M | $6M | |
| Capital Leases | $24M | $24M | $26M | $29M | $19M | $21M | $21M | · | · | · | · | · | |
| Deferred Tax | · | · | $0 | $6M | $10M | $12M | $4M | $4M | $5M | $7M | $7M | $8M | |
| Other Non-current Liabilities | $701.0K | $772.0K | $404.0K | $398.0K | $1M | $1M | $357.0K | $550.0K | $660.0K | $2M | $781.0K | $894.0K | |
| Common Stock | $139.0K | $144.0K | $147.0K | $146.0K | $144.0K | $143.0K | $143.0K | $142.0K | $147.0K | $146.0K | $150.0K | $149.0K | |
| Retained Earnings | $61M | $72M | $128M | $211M | $226M | $221M | $245M | $218M | $200M | $168M | $136M | $105M | |
| AOCI | $-5M | $-7M | $-6M | $-6M | $-6M | $-5M | $-6M | $-6M | $-5M | $-7M | $-7M | $-4M | |
| Stockholders' Equity | $143M | $154M | $212M | $286M | $287M | $272M | $288M | $264M | $263M | $223M | $211M | $178M | |
| Liabilities + Equity | $190M | $203M | $271M | $349M | $348M | $366M | $331M | $279M | $283M | $240M | $236M | $193M | |
| Shares Outstanding | 13,889,000 | 14,416,000 | 14,660,000 | 14,625,000 | 14,441,000 | 14,329,000 | 14,308,000 | 14,210,000 | 14,688,000 | 14,627,000 | 15,037,000 | 14,851,703 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $7M | $6M | $7M | $6M | $6M | $5M | $6M | $4M | $4M | $4M | $5M | |
| Stock-based Comp | $10M | $13M | $15M | $14M | $11M | $5M | $6M | $11M | $6M | $3M | $2M | $2M | |
| Deferred Tax | $-7.0K | $260.0K | $-6M | $-5M | $-2M | $-4M | $794.0K | $-2M | $-1M | $-65.0K | $-747.0K | $815.0K | |
| Amort. of Intangibles | $400.0K | $700.0K | $600.0K | $600.0K | $8M | $7M | $1M | $1M | $1M | $1M | $1M | $2M | |
| Operating Cash Flow | $11M | $5M | $-2M | $4M | $8M | $13M | $37M | $35M | $41M | $24M | $40M | $40M | |
| CapEx | $7M | $8M | $5M | $7M | $5M | $2M | $3M | $5M | $9M | $14M | $9M | $2M | |
| Investing Cash Flow | $-401.0K | $-8M | $-5M | $-7M | $-3M | $-71M | $40M | $-50M | $-12M | $-7M | $-30M | $-8M | |
| Debt Issued | · | · | · | $0 | $0 | $50M | $0 | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $-350.0K | · | · | · | · | · | · | |
| Stock Repurchased | $9M | $11M | $5M | $0 | $0 | $0 | $30M | $30M | · | $25M | · | · | |
| Net Stock Activity | $-9M | $-11M | · | · | $0 | $0 | $-30M | $-30M | · | $-25M | · | · | |
| Financing Cash Flow | $-11M | $-13M | $-6M | $-5M | $-7M | $-4M | $-8M | $-29M | $314.0K | $-24M | $1M | $5M | |
| Net Change in Cash | $322.0K | $-16M | $-13M | $-8M | $-1M | $-62M | $68M | $-44M | $29M | $-6M | $11M | $37M | |
| Taxes Paid | $1M | $4M | $3M | $106.0K | $1M | $993.0K | $9M | · | · | · | · | · | |
| Free Cash Flow | $4M | $-2M | · | $-3M | $3M | $11M | $34M | $30M | $32M | $10M | $30M | $38M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.6% | 63.4% | · | 59.9% | 56.1% | 52.9% | · | · | · | · | · | · | |
| Operating Margin | -9.8% | -4.2% | · | -12.4% | 1.8% | -21.7% | 29.9% | 20.6% | 40.3% | 48.9% | 51.8% | 58.2% | |
| Net Margin | -9.6% | -47.0% | · | -9.5% | 2.8% | -18.4% | 23.7% | 17.7% | 28.1% | 31.5% | 33.1% | 36.3% | |
| Pretax Margin | -8.2% | -2.3% | · | -12.0% | 1.6% | -21.9% | 31.5% | 22.0% | 40.7% | 49.2% | 51.9% | 58.2% | |
| EBITDA Margin | -9.8% | -4.2% | · | -12.4% | 1.8% | -21.7% | 29.9% | 20.6% | 40.3% | 48.9% | 51.8% | 58.2% | |
| ROA | -5.5% | -23.8% | · | -4.3% | 1.2% | -6.9% | 8.9% | 6.7% | 12.2% | 13.7% | 14.3% | 21.9% | |
| ROE | -7.5% | -33.8% | · | -5.2% | 1.4% | -8.6% | 9.5% | 7.2% | 13.1% | 15.0% | 15.8% | 24.4% | |
| ROIC | -8.3% | -10.6% | · | -5.4% | 1.6% | -8.7% | 8.9% | 6.7% | 11.9% | 14.5% | 14.5% | 21.5% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 4.9 | · | 6.1 | 5.7 | 4.8 | 14.4 | 18.0 | 15.8 | 19.4 | 10.2 | 23.3 | |
| Quick Ratio | 4.8 | 4.4 | · | 5.6 | 4.2 | 3.3 | 12.8 | 15.9 | 13.9 | 17.3 | 9.3 | 20.8 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | · | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | |
| Inventory Turnover | 2.3 | 1.8 | · | 1.7 | 1.6 | 1.4 | 1.3 | 1.4 | 1.4 | 1.6 | 1.5 | 1.8 | |
| Receivables Turnover | 4.8 | 4.8 | · | 4.4 | 5.5 | 5.5 | 5.2 | 4.7 | 4.4 | 4.2 | 4.8 | 5.9 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $10.33 | $10.68 | · | $19.53 | $19.88 | $19.01 | $20.16 | $18.55 | $17.94 | $15.23 | $14.02 | $11.99 | |
| Revenue / Share | $7.87 | $8.15 | · | $10.73 | $10.10 | $9.17 | $7.97 | $7.19 | $7.53 | $6.84 | $6.07 | $6.92 | |
| Cash Flow / Share | $0.78 | $0.37 | · | $0.30 | $0.57 | $0.92 | $2.57 | $2.38 | $2.71 | $1.57 | $2.55 | $2.62 | |
| Cash / Share | $4.14 | $3.86 | · | $5.90 | $6.54 | $6.69 | $11.01 | $6.27 | $9.07 | $7.13 | $7.36 | $6.74 | |
| EPS (TTM) | $-0.76 | $-3.83 | $-5.64 | $-1.02 | $0.28 | $-1.69 | $1.89 | $1.27 | $2.11 | $2.15 | $2.01 | $2.51 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -5.9% | -0.73% | 6.1% | -23.0% | 13.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.30% | -6.7% | -2.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.9% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $113M | $120M | $121M | $114M | $148M | $130M | $115M | $106M | $113M | $103M | $93M | $106M | |
| Net Income TTM | $-11M | $-56M | $-83M | $-15M | $4M | $-24M | $27M | $19M | $32M | $33M | $31M | $38M | |
| Market Cap | $133M | $237M | · | $433M | $517M | $649M | $742M | $478M | $792M | $716M | $574M | $605M | |
| P/E | -12.6 | -4.3 | -4.0 | -29.0 | 128.0 | -26.8 | 27.4 | 26.5 | 25.5 | 22.8 | 19.0 | 16.2 | |
| P/S | 1.2 | 2.0 | · | 3.8 | 3.5 | 5.0 | 6.5 | 4.5 | 7.0 | 6.9 | 6.2 | 5.7 | |
| P/B | 0.9 | 1.5 | · | 1.5 | 1.8 | 2.4 | 2.6 | 1.8 | 3.0 | 3.2 | 2.7 | 3.4 | |
| P / Tangible Book | 1.0 | 1.6 | 1.6 | 2.1 | 2.6 | 3.8 | · | · | · | · | · | · | |
| P / Cash Flow | 11.9 | 43.9 | · | 98.2 | 61.6 | 49.6 | 20.0 | 13.7 | 19.4 | 30.1 | 14.7 | 15.1 | |
| P / FCF | 30.6 | -101.8 | · | -140.7 | 159.0 | 56.7 | 21.7 | 15.8 | 24.9 | 73.2 | 19.2 | 15.7 | |
| Earnings Yield | -7.9% | -23.3% | -24.9% | -3.5% | 0.78% | -3.7% | 3.6% | 3.8% | 3.9% | 4.4% | 5.3% | 6.2% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $30M | $31M | $28M | $28M | $26M | $31M | $30M | $31M | $29M | $-3M | $41M | $44M | $38M | $-3M | $40M | |
| Cost of Revenue | $11M | $11M | $11M | $12M | $14M | $11M | $13M | $10M | $10M | $10M | $-9M | $17M | $15M | $15M | $-7M | $17M | |
| Gross Profit | $21M | $19M | $19M | $16M | $14M | $15M | $17M | $19M | $20M | $19M | $6M | $25M | $29M | $23M | $4M | $23M | |
| R&D Expense | $7M | $7M | $6M | $7M | $6M | $6M | $7M | $6M | $7M | $6M | $-3M | $8M | $9M | $8M | $-2M | $7M | |
| SG&A Expense | $11M | $18M | $12M | $12M | $12M | $13M | $11M | $14M | $16M | $15M | $-16M | $25M | $24M | $27M | $-11M | $21M | |
| Operating Expenses | $18M | $24M | $19M | $19M | $19M | $19M | $18M | $19M | $22M | $21M | $-19M | $33M | $33M | $35M | $-13M | $29M | |
| Operating Income | $3M | $-5M | $646.0K | $-3M | $-4M | $-4M | $-705.0K | $-81.0K | $-2M | $-3M | $25M | $-8M | $-4M | $-13M | $16M | $-6M | |
| Pretax Income | $3M | $-5M | $764.0K | $-2M | $-4M | $-4M | $39.0K | $325.0K | $-1M | $-2M | $25M | $-7M | $-3M | $-12M | $17M | $-5M | |
| Income Tax | $71.0K | $235.0K | $-1M | $939.0K | $681.0K | $89.0K | $3M | $2M | $1M | $43.0K | $9M | $-463.0K | $-329.0K | $-2M | $5M | $-1M | |
| Net Income | $3M | $-5M | $292.0K | $-2M | $-4M | $-5M | $-22M | $-30M | $-88.0K | $-5M | $-63M | $-7M | $-3M | $-10M | $-5M | $-4M | |
| EPS (Basic) | $0.25 | $-0.37 | $0.02 | $-0.16 | $-0.28 | $-0.34 | $-1.48 | $-2.03 | $-0.01 | $-0.31 | $-4.29 | $-0.45 | $-0.19 | $-0.71 | $-0.33 | $-0.29 | |
| EPS (Diluted) | $0.24 | $-0.37 | $0.02 | $-0.16 | $-0.28 | $-0.34 | $-1.49 | $-2.03 | $0.00 | $-0.31 | $-4.29 | $-0.45 | $-0.19 | $-0.71 | $-0.33 | $-0.29 | |
| Shares (Basic) | 13,330,000 | 13,531,000 | · | 14,419,000 | 14,364,000 | 14,297,000 | · | 14,768,000 | 14,839,000 | 14,698,000 | · | 14,635,000 | 14,688,000 | 14,653,000 | · | 14,603,000 | |
| Shares (Diluted) | 13,717,000 | 13,531,000 | · | 14,419,000 | 14,517,000 | 14,297,000 | · | 14,768,000 | 14,856,000 | 14,698,000 | · | 14,635,000 | 14,688,000 | 14,653,000 | · | 14,603,000 | |
| EBITDA | $3M | $-5M | · | $-3M | $-4M | $-4M | · | $-28M | $161.0K | $-5M | · | $-8M | $-4M | $-13M | · | $-6M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $41M | $57M | $58M | $53M | $53M | $56M | $62M | $63M | $69M | · | $71M | $65M | $80M | · | $88M | |
| Short-term Investments | · | $26M | $24M | $22M | $24M | $22M | $24M | $28M | $34M | $32M | · | $35M | $37M | $31M | · | $34M | |
| Receivables | $29M | $26M | $24M | $22M | $24M | $22M | $24M | $28M | $34M | $32M | · | $35M | $37M | $31M | · | · | |
| Inventory | $29M | $23M | $19M | $16M | $17M | $21M | $24M | $40M | $51M | $49M | · | $44M | $43M | $41M | · | $37M | |
| Prepaid Expense | $3M | $4M | $3M | $5M | $5M | $6M | $5M | $6M | $7M | $9M | · | $8M | $8M | $9M | · | $9M | |
| Current Assets | $99M | $94M | $103M | $102M | $99M | $103M | $114M | $136M | $155M | $159M | · | $157M | $152M | $160M | · | $168M | |
| PP&E (Net) | $40M | $40M | $40M | $41M | $41M | $40M | $39M | $45M | $48M | $46M | · | $46M | $48M | $49M | · | $47M | |
| PP&E (Gross) | $94M | $92M | $92M | · | $90M | $88M | $85M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $54M | $53M | $51M | · | $49M | $48M | $46M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $7M | $7M | $8M | $7M | $7M | $7M | $7M | $7M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | · | $69M | $71M | $73M | · | $77M | |
| Other Non-current Assets | $3M | $4M | $4M | $6M | $6M | $6M | $6M | $11M | $20M | $18M | · | $19M | $19M | $18M | · | $18M | |
| Total Assets | $183M | $179M | $190M | $189M | $188M | $191M | $203M | $231M | $263M | $264M | · | $328M | $329M | $339M | · | $348M | |
| Accounts Payable | $6M | $6M | $6M | $5M | $5M | $5M | $6M | $7M | $10M | $10M | · | $8M | $8M | $9M | · | $8M | |
| Current Liabilities | $22M | $21M | $22M | $19M | $16M | $18M | $23M | $25M | $26M | $28M | · | $28M | $23M | $29M | · | $26M | |
| Capital Leases | $23M | $24M | $24M | $23M | $23M | $24M | $24M | $25M | $26M | $26M | · | $27M | $28M | $28M | · | $29M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $2M | $3M | $4M | · | $7M | |
| Other Non-current Liabilities | $730.0K | $726.0K | $701.0K | $761.0K | $756.0K | $744.0K | $772.0K | $806.0K | $407.0K | $404.0K | · | $400.0K | $401.0K | $399.0K | · | $474.0K | |
| Common Stock | $134.0K | $133.0K | $139.0K | $144.0K | $144.0K | $143.0K | $144.0K | $147.0K | $148.0K | $148.0K | · | $146.0K | $147.0K | $147.0K | · | $146.0K | |
| Retained Earnings | $59M | $56M | $61M | $60M | $63M | $67M | $72M | $94M | $123M | $124M | · | $191M | $198M | $200M | · | $216M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-6M | $-7M | $-6M | $-6M | $-6M | · | $-7M | $-6M | $-6M | · | $-7M | |
| Stockholders' Equity | $137M | $134M | $143M | $147M | $148M | $148M | $154M | $180M | $210M | $209M | $212M | $270M | $274M | $278M | $286M | $285M | |
| Liabilities + Equity | $183M | $179M | $190M | $189M | $188M | $191M | $203M | $231M | $263M | $264M | · | $328M | $329M | $339M | · | $348M | |
| Shares Outstanding | 13,383,000 | 13,357,000 | 13,889,000 | 14,421,000 | 14,418,000 | 14,336,000 | 14,416,000 | 14,694,000 | 14,839,000 | 14,821,000 | · | 14,637,000 | 14,657,000 | 14,741,000 | · | 14,607,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $2M | $7M | $2M | $2M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Deferred Tax | $129.0K | $108.0K | $-25.0K | $3.0K | $-3.0K | $18.0K | $234.0K | $-184.0K | $17.0K | $193.0K | $-2M | $-1M | $-904.0K | $-2M | $-2M | $-1M | |
| Amort. of Intangibles | · | · | $0 | $0 | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $100.0K | $-5M | $2M | $2M | $2M | $-5M | $2M | |
| Restructuring | $519.0K | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-684.0K | $-5M | $5M | $7M | $-189.0K | $-130.0K | $2M | $5M | $-1M | $-126.0K | $4M | $6M | $-8M | $-4M | $481.0K | $3M | |
| CapEx | $1M | $1M | $648.0K | $2M | $1M | $3M | $1M | $1M | $3M | $2M | $2M | $741.0K | $1M | $1M | $3M | $2M | |
| Investing Cash Flow | $-1M | $-1M | $198.0K | $-2M | $-539.0K | $2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-741.0K | $-1M | $-1M | $-3M | $-2M | |
| Stock Repurchased | $853.0K | $9M | $6M | $0 | $0 | $4M | $6M | $4M | $1M | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | $-9M | · | · | · | $-4M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-701.0K | $-10M | $-5M | $-13.0K | $179.0K | $-5M | $-5M | $-4M | $-1M | $-2M | $342.0K | $-110.0K | $-5M | $-2M | $667.0K | $-5M | |
| Net Change in Cash | $-3M | $-16M | $-509.0K | $5M | $-204.0K | $-4M | $-5M | $-454.0K | $-6M | $-4M | $2M | $6M | $-15M | $-7M | $-1M | $-4M | |
| Free Cash Flow | · | $-6M | · | · | · | $-3M | · | · | · | $-2M | · | · | · | $-5M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.1% | 64.1% | · | 56.0% | 50.9% | 56.1% | · | 3.7% | 65.3% | 60.8% | · | 60.2% | 65.4% | 60.2% | · | 56.6% | |
| Operating Margin | 9.1% | -18.5% | · | -11.6% | -14.8% | -16.4% | · | -72.3% | 0.38% | -12.5% | · | -18.5% | -8.2% | -33.1% | · | -14.4% | |
| Net Margin | 10.2% | -17.1% | · | -8.4% | -14.1% | -18.6% | · | -77.2% | -0.21% | -11.1% | · | -15.9% | -6.2% | -27.3% | · | -10.4% | |
| Pretax Margin | 10.4% | -16.3% | · | -8.0% | -14.1% | -14.8% | · | -71.2% | 1.8% | -11.0% | · | -17.0% | -6.9% | -31.7% | · | -13.3% | |
| EBITDA Margin | 9.1% | -18.5% | · | -11.6% | -14.8% | -16.4% | · | -72.3% | 0.38% | -12.5% | · | -18.5% | -8.2% | -33.1% | · | -14.4% | |
| ROA | 1.8% | -2.7% | · | -1.1% | -1.8% | -2.1% | · | -10.7% | -0.03% | -1.5% | · | -1.9% | -0.80% | -3.0% | · | -1.2% | |
| ROE | 2.3% | -3.6% | · | -1.4% | -2.2% | -2.7% | · | -13.3% | -0.04% | -1.9% | · | -2.4% | -0.98% | -3.7% | · | -1.5% | |
| ROIC | 2.1% | -4.3% | · | -3.1% | -3.3% | -2.9% | · | -16.9% | -0.01% | -2.5% | · | -2.6% | -1.2% | -3.9% | · | -1.6% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 4.5 | · | 5.3 | 6.2 | 5.7 | · | 5.3 | 5.9 | 5.6 | · | 5.6 | 6.5 | 5.6 | · | 6.4 | |
| Quick Ratio | 3.0 | 4.4 | · | 5.4 | 6.3 | 5.4 | · | 4.7 | 5.0 | 4.7 | · | 5.0 | 5.9 | 4.9 | · | 4.6 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.3 | · | 0.9 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.1 | 1.0 | 1.0 | · | 1.2 | 1.2 | 1.3 | · | 1.2 | 1.3 | 1.3 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $10.26 | $10.02 | · | $10.18 | $10.24 | $10.35 | · | $12.24 | $14.17 | $14.07 | · | $18.48 | $18.70 | $18.83 | · | $19.51 | |
| Revenue / Share | $2.38 | $2.19 | · | $1.93 | $1.94 | $1.83 | · | $2.62 | $2.83 | $2.76 | · | $2.83 | $3.02 | $2.59 | · | $2.76 | |
| Cash Flow / Share | · | $-0.36 | · | · | · | $-0.01 | · | · | · | $-0.01 | · | · | · | $-0.25 | · | · | |
| Cash / Share | $2.87 | $3.07 | · | $4.02 | $3.69 | $3.72 | · | $4.24 | $4.23 | $4.63 | · | $4.83 | $4.44 | $5.41 | · | $6.01 | |
| EPS (TTM) | $-0.27 | $-0.79 | · | $-2.27 | $-4.14 | $-3.86 | · | $-6.63 | $-5.05 | $-5.24 | · | $-1.68 | $-1.52 | $-1.53 | · | $-1.10 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $121M | $116M | · | $113M | $115M | $117M | · | $86M | $98M | $112M | · | $121M | $120M | $115M | · | $152M | |
| Net Income TTM | $-4M | $-11M | · | $-33M | $-61M | $-57M | · | $-98M | $-74M | $-77M | · | $-25M | $-22M | $-22M | · | $-16M | |
| Market Cap | $196M | $194M | · | $136M | $153M | $215M | · | $363M | $376M | $376M | · | $273M | $381M | $423M | · | $348M | |
| P/E | -54.2 | -18.4 | · | -4.1 | -2.6 | -3.9 | · | -3.7 | -5.0 | -4.8 | · | -11.1 | -17.1 | -18.8 | · | -21.6 | |
| P/S | 1.6 | 1.7 | · | 1.2 | 1.3 | 1.8 | · | 4.2 | 3.8 | 3.4 | · | 2.3 | 3.2 | 3.7 | · | 2.3 | |
| P/B | 1.4 | 1.4 | · | 0.9 | 1.0 | 1.5 | · | 2.0 | 1.8 | 1.8 | · | 1.0 | 1.4 | 1.5 | · | 1.2 | |
| P / Tangible Book | 1.5 | 1.6 | · | 1.0 | 1.1 | 1.6 | · | 2.1 | 1.9 | 1.9 | · | 1.4 | 1.9 | 2.1 | · | 1.7 | |
| P / Cash Flow | · | -40.0 | · | · | · | -1657.5 | · | · | · | -2987.7 | · | · | · | -117.0 | · | · | |
| Earnings Yield | -1.8% | -5.5% | · | -24.1% | -39.1% | -25.7% | · | -26.8% | -19.9% | -20.6% | · | -9.0% | -5.9% | -5.3% | · | -4.6% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $113M | $120M | $121M | $114M | $148M |
| Gross Margin % | 56.6% | 63.4% | · | 59.9% | 56.1% |
| Operating Margin % | -9.8% | -4.2% | · | -12.4% | 1.8% |
| Net Income | $-11M | $-56M | $-83M | $-15M | $4M |
| Diluted EPS | $-0.76 | $-3.83 | $-5.64 | $-1.02 | $0.28 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 4.7 | 4.9 | · | 6.1 | 5.7 |
| Quick Ratio | 4.8 | 4.4 | · | 5.6 | 4.2 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $4M | $-2M | · | $-3M | $3M |
Institutional owners (13F) 145 filers · $180.6M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
145
Value held
$180.6M
New positions
20
Exited positions
12
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 20 (-6 vs prior Q) | 12 (-4 vs prior Q) | 46 (-3 vs prior Q) | 40 (+3 vs prior Q) | -63K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $21,208,688 | 1,449,671 | 11.75% | Shares |
| Caligan Partners LP | $20,995,952 | 1,435,130 | 11.63% | Shares |
| MORGAN STANLEY | $8,987,502 | 614,320 | 4.98% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $8,370,013 | 572,113 | 4.64% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $8,190,546 | 559,846 | 4.54% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $7,748,633 | 529,640 | 4.29% | Shares |
| VANGUARD GROUP INC | $7,487,776 | 779,165 | 4.15% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $7,043,131 | 481,417 | 3.90% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $6,599,818 | 451,095 | 3.66% | Shares |
| CAPITAL MANAGEMENT CORP /VA | $6,561,167 | 448,474 | 3.63% | Shares |
| DEUTSCHE BANK AG\ | $5,172,466 | 353,552 | 2.86% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $4,852,628 | 331,577 | 2.69% | Shares |
| STATE STREET CORP | $4,563,038 | 311,896 | 2.53% | Shares |
| TWO SIGMA INVESTMENTS, LP | $3,700,863 | 252,964 | 2.05% | Shares |
| D. E. Shaw & Co., Inc. | $3,585,316 | 245,066 | 1.99% | Shares |
| GOLDMAN SACHS GROUP INC | $3,477,873 | 237,722 | 1.93% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3,182,464 | 217,530 | 1.76% | Shares |
| Nuveen, LLC | $2,290,151 | 156,538 | 1.27% | Shares |
| Quantinno Capital Management LP | $2,271,410 | 155,257 | 1.26% | Shares |
| UBS Group AG | $2,133,288 | 145,816 | 1.18% | Shares |
| Man Group plc | $2,058,617 | 140,712 | 1.14% | Shares |
| Hillsdale Investment Management Inc. | $2,030,951 | 138,821 | 1.12% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,658,662 | 113,374 | 0.92% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1,560,202 | 106,644 | 0.86% | Shares |
| AMERICAN CENTURY COMPANIES INC | $1,515,068 | 103,559 | 0.84% | Shares |
| NORTHERN TRUST CORP | $1,435,701 | 98,134 | 0.80% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $1,298,486 | 88,755 | 0.72% | Shares |
| GLOBEFLEX CAPITAL L P | $1,281,588 | 87,600 | 0.71% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,280,520 | 87,527 | 0.71% | Shares |
| JANE STREET GROUP, LLC | $1,247,310 | 85,257 | 0.69% | Shares |
| TWO SIGMA ADVISERS, LP | $1,215,502 | 126,483 | 0.67% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,123,189 | 76,773 | 0.62% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1,049,819 | 71,758 | 0.58% | Shares |
| Cove Street Capital, LLC | $958,386 | 101,956 | 0.53% | Shares |
| IRONWOOD INVESTMENT MANAGEMENT LLC | $958,309 | 65,503 | 0.53% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $935,632 | 63,953 | 0.52% | Shares |
| JPMORGAN CHASE & CO | $813,768 | 54,215 | 0.45% | Shares |
| Assenagon Asset Management S.A. | $793,792 | 40,376 | 0.44% | Shares |
| DIKER MANAGEMENT LLC | $785,000 | 53,662 | 0.43% | Shares |
| FMR LLC | $775,095 | 52,980 | 0.43% | Shares |
| AMERIPRISE FINANCIAL INC | $765,953 | 52,355 | 0.42% | Shares |
| BARCLAYS PLC | $765,427 | 52,319 | 0.42% | Shares |
| HSBC HOLDINGS PLC | $727,024 | 50,105 | 0.40% | Shares |
| Indivisible Partners | $676,696 | 46,254 | 0.37% | Shares |
| Advyzon Investment Management, LLC | $667,450 | 45,622 | 0.37% | Shares |
| Cerity Partners LLC | $594,885 | 40,662 | 0.33% | Shares |
| Palumbo Wealth Management LLC | $586,312 | 40,076 | 0.32% | Shares |
| Bank of New York Mellon Corp | $567,252 | 38,773 | 0.31% | Shares |
| Corient Private Wealth LP | $518,123 | 35,415 | 0.29% | Shares |
| STATE OF WISCONSIN INVESTMENT BOARD | $495,957 | 33,900 | 0.27% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Caligan Partners LP, David Johnson ×6 filings | Jan. 27, 2026 | 9.95% | Amendment | · | SEC |
| ANDREW E. GOLD, RONIT GOLD | Nov. 15, 2004 | · | Initial filing | Passive investment | SEC |
| Undisclosed reporting person | April 22, 2004 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 43 insiders · 20 officers · 18 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Stephen D. Griffin | President and CEO | June 3, 2026 M | 45,973 | 1 | 0 | $149,938 |
| Joseph G Darling | President and CEO; Director | July 27, 2019 F | 20,289 | 0 | 0 | $0 |
| Charles H Sherwood | CEO and Director | March 2, 2018 A | 189,891 | 0 | 0 | $0 |
| Michael L Levitz | EVP, CFO, Treasurer | March 15, 2024 A | 46,955 | 0 | 0 | $0 |
| Sylvia Cheung | Chief Financial Officer | Feb. 25, 2020 A | 49,281 | 0 | 0 | $0 |
| Kevin W Quinlan | Chief Financial Officer | March 27, 2013 S | 27,112 | 0 | 0 | $0 |
| Francesco J Luppino | Chief Operating Officer | Feb. 3, 2015 A | 5,979 | 0 | 0 | $0 |
| Ian Mcleod | SVP, CAO & Treasurer | March 19, 2026 A | 24,107 | 0 | 0 | $0 |
| David Colleran | EVP, General Counsel, Corp Sec | March 15, 2026 M | 67,570 | 0 | 0 | $0 |
| Anne Nunes | SVP, Chief Operations Officer | March 17, 2025 M | 20,654 | 0 | 0 | $0 |
| Thomas Finnerty | EVP, Human Resources | March 9, 2022 M | 24,598 | 0 | 0 | $0 |
| James Loerop | EVP Business Development | July 8, 2021 M | 5,592 | 0 | 0 | $0 |
| Richard Hague | Chief Commercial Officer | Feb. 27, 2019 A | 21,419 | 0 | 0 | $0 |
| Edward S. Ahn | Chief Tech & Strategy Officer | Feb. 27, 2019 A | 6,575 | 0 | 0 | $0 |
| Dana M. Alexander | Chief Operations Officer | Jan. 27, 2017 A | · | 0 | 0 | $0 |
| Stephen R. Mascioli | Chief Medical Officer | April 4, 2016 A | · | 0 | 0 | $0 |
| Carol A Barnett | Chief Commercial Officer | Jan. 27, 2014 A | 6,100 | 0 | 0 | $0 |
| John W Sheets JR | Chief Scientific Officer | Oct. 2, 2013 A | 10,000 | 0 | 0 | $0 |
| William Mrachek | Vice President, Human Resource | Jan. 18, 2011 A | 6,854 | 0 | 0 | $0 |
| Constance H Garrison | VP Reg.,Clinical & Qlty. Sys. | Nov. 8, 2006 A | · | 0 | 0 | $0 |
| Stephen Richard | Director | June 18, 2026 A | 58,273 | 0 | 0 | $0 |
| Joseph H Capper | Director | June 18, 2026 A | 30,805 | 0 | 0 | $0 |
| Sheryl L Conley | Director | June 18, 2026 A | 52,970 | 0 | 0 | $0 |
| John B Henneman III | Director | June 18, 2026 A | 65,273 | 1 | 0 | $73,300 |
| Cheryl R Blanchard | Director | March 15, 2026 M | 258,788 | 0 | 0 | $0 |
| Glenn R. Larsen | Director | June 20, 2025 A | 50,258 | 0 | 0 | $0 |
| Susan L N Vogt | Director | June 20, 2025 A | 50,213 | 0 | 0 | $0 |
| William R Jellison | Director | June 20, 2025 A | 20,403 | 0 | 0 | $0 |
| Jeffery S Thompson | Director | June 14, 2023 A | 31,575 | 0 | 0 | $0 |
| Raymond J Land | Director | June 16, 2021 A | 12,125 | 0 | 0 | $0 |
| Joseph I Bower | Director | Feb. 25, 2020 A | 17,117 | 0 | 0 | $0 |
| Steve E Wheeler | Director | Jan. 24, 2018 A | 34,594 | 0 | 0 | $0 |
| John C Moran | Director | Aug. 7, 2015 S | 14,803 | 0 | 0 | $0 |
| Eugene A Davidson | Director | Jan. 18, 2011 A | 71,763 | 0 | 0 | $0 |
| Harvey S Sadow | Director | Sept. 8, 2006 M | 10,000 | 0 | 0 | $0 |
| Fidia Farmaceutici S.p.A. | 10% owner | Aug. 6, 2013 S | 711,192 | 0 | 0 | $0 |
| Gary P Fischetti | · | Aug. 4, 2026 P | 54,015 | 2 | 0 | $41,060 |
| Carol A Toth | · | Jan. 26, 2006 A | · | 0 | 0 | $0 |
| Samuel F Mckay | · | Jan. 24, 2006 A | 0 | 0 | 0 | $0 |
| Peter Litman | · | Oct. 3, 2005 A | · | 0 | 0 | $0 |
| James E Oneill | · | Feb. 10, 2005 A | · | 0 | 0 | $0 |
| Elizabeth Chen | · | Oct. 4, 2004 A | · | 0 | 0 | $0 |
| William J Knight | · | Sept. 27, 2004 M | 47,500 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 24 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.57% | 5,507 SH | Oct. 23, 2026 | Daily |
| IWC · iShares Trust | 0.06% | 38,986 SH | Sept. 11, 2026 | Daily |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.02% | 5,502 NS | July 31, 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.01% | 56,771 NS | July 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 15,040 SH | Oct. 23, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.01% | 1,339 SH | Oct. 23, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 65,730 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 9,977 SH | Aug. 19, 2026 | Daily |
| PKW · Invesco Exchange-Traded Fund Trust | 0.01% | 7,846 SH | Oct. 22, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 305,635 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 41,182 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 800 NS | July 31, 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.00% | 7,426 NS | July 31, 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.00% | 6,027 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 1,000 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 6,180 SH | Sept. 4, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.00% | 733 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 1,436 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 1,888 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 162,458 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 397,824 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,066 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.00% | 900 NS | July 31, 2026 | N-PORT |
| IWN · iShares Trust | · | 104,276 SH | Sept. 11, 2026 | Daily |
ANIK Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$23.00
+7.4%
3 37.5%
Strong Buy
4 50.0%
Buy
1 12.5%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-10-21Mean target $23.00 +7.4%
Low$23.00
Mean$23.00
High$23.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | · |
| SRZN | · | · | · | · | · | · |
| PRLD | · | -2.2 | 73.4% | -819.6% | -137.7% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
| SABS | · | · | · | · | · | · |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 29, 2026